|
AGIO | Agios Pharmaceuticals, Inc. |
|
|
AGIO | Agios Pharmaceuticals, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.76 |
| Leverage | 8.03% |
| Market Cap | $ 1.6B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -411.4m |
| Margin | -738.75% |
Agios Pharmaceuticals, Inc., a biopharmaceutical company, is dedicated to drug discovery and development in the field of cellular metabolism and adjacent areas of biology. The company is headquartered in Cambridge, Massachusetts.